Nephron Sterile Compounding Center LLC
Doing business as Nephron S.C Inc. Nephron 503B Outsourcing Facility Part of Nephron Pharmaceuticals Corporation
- UEI
- QMJBTTY9BRF8
- CAGE
- 7XQU1
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- Corporate family
-
-
Parent
Nephron Pharmaceuticals Corporation
S7MNQGDTFDN9
-
Parent
Nephron Pharmaceuticals Corporation
S7MNQGDTFDN9
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | -$38,400 |
| FY2024 | -$28,398 |
| FY2023 | $51,825 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Nephron Sterile Compounding Center LLC, doing business as Nephron S.C Inc., is a woman-owned small business and limited liability company registered in the System for Award Management (SAM) since August 30, 2017. Located in West Columbia, South Carolina, the company specializes in pharmaceutical product manufacturing and distribution, with a particular focus on sterile compounding services through its 503B Outsourcing Facility Division. The company has established itself as a reliable provider of specialized pharmaceutical products to federal healthcare agencies, leveraging its status as a self-certified small disadvantaged business and woman-owned enterprise.
Nephron Sterile Compounding Center LLC has consistently secured federal contract awards from key healthcare agencies, primarily the Defense Health Agency (DHA) and the Indian Health Service (IHS), with contract values ranging from $3,450 to $57,600. The company's primary federal contract offerings include providing specialized pharmaceutical injection products such as Phenylephrine HCI Injection, Succinylcholine Chloride for Injection, Preservative Free Rocuronium Bromide for Injection, and Buffered Lidocaine Buffer in Sodium Bicarbonate. These contracts are typically structured as Blanket Purchase Agreements (BPAs) or purchase orders with firm fixed prices, with ultimate completion dates extending through December 2027. The contracts have been consistently awarded on an unrestricted basis with no specific set-aside designations, indicating the company's competitive positioning in providing pharmaceutical supplies to federal healthcare institutions. Nephron has demonstrated a consistent track record of delivering medical and pharmaceutical supplies to support healthcare programs across different federal agencies.
Quick answers
Is Nephron Sterile Compounding Center LLC registered in SAM.gov?
Nephron Sterile Compounding Center LLC's SAM.gov registration expired on November 11, 2025.
What is Nephron Sterile Compounding Center LLC's CAGE code?
Nephron Sterile Compounding Center LLC's CAGE code is 7XQU1, and its Unique Entity ID (UEI) is QMJBTTY9BRF8.
What is Nephron Sterile Compounding Center LLC's most recent federal award?
Nephron Sterile Compounding Center LLC's most recent federal contract award is Pharmaceuticals anesthesia pre-filled syringes (W81K0025FA011), from Medical Command (Army), on January 30, 2025.
On GovTribe
See Nephron Sterile Compounding Center LLC's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors